Journey Medical Corporation (DERM) Stock Overview
Explore Journey Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.
Journey Medical Corporation (DERM)
Key Financials
Key Financials
Market Cap
182.2M
P/E Ratio
-17.15
EPS (TTM)
$-0.37
ROE
-0.36%
DERM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Journey Medical Corporation (DERM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.72.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.15 and a market capitalization of 182.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.